Athena Matakidou

Athena Matakidou

UNVERIFIED PROFILE

Are you Athena Matakidou?   Register this Author

Register author
Athena Matakidou

Athena Matakidou

Publications by authors named "Athena Matakidou"

Are you Athena Matakidou?   Register this Author

26Publications

600Reads

24Profile Views

Dose escalation of axitinib on disease progression as a strategy in the treatment of metastatic renal cell carcinoma.

ESMO Open 2018 5;3(7):e000445. Epub 2018 Nov 5.

Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2018-000445DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241974PMC
November 2018

Prognostic effect of cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma: a comparative study using inverse probability of treatment weighting.

World J Urol 2018 Mar 18;36(3):417-425. Epub 2017 Dec 18.

Department of Urology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-017-2154-xDOI Listing
March 2018

Loss of PBRM1 rescues VHL dependent replication stress to promote renal carcinogenesis.

Nat Commun 2017 12 11;8(1):2026. Epub 2017 Dec 11.

Department of Oncology, University of Cambridge, CRUK Cambridge institute, Cambridge, CB2 0RE, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-017-02245-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725450PMC
December 2017

Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.

Nat Genet 2017 03;49(4):651

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng0417-651aDOI Listing
March 2017

A minimally invasive, lentiviral based method for the rapid and sustained genetic manipulation of renal tubules.

Sci Rep 2015 Jun 5;5:11061. Epub 2015 Jun 5.

Department of Oncology, University of Cambridge, CRUK Cambridge institute, Cambridge, CB2 0RE, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep11061DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457145PMC
June 2015

Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.

Nat Genet 2014 Jul 1;46(7):736-41. Epub 2014 Jun 1.

1] Center for Genomic Medicine, Department of Community and Family Medicine, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire, USA. [2] [3].

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.3002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074058PMC
July 2014

Improving clinical trial recruitment: experience of a tertiary renal oncology centre.

Oncology 2013 6;85(5):297-8. Epub 2013 Nov 6.

Cambridge University Health Partners, Addenbrooke's Hospital, Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000355688DOI Listing
January 2014

Variation in TP63 is associated with lung adenocarcinoma in the UK population.

Cancer Epidemiol Biomarkers Prev 2011 Jul 24;20(7):1453-62. Epub 2011 May 24.

Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-11-0042DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108419PMC
July 2011

Chromosome 15q25 (CHRNA3-CHRNA5) variation impacts indirectly on lung cancer risk.

PLoS One 2011 Apr 29;6(4):e19085. Epub 2011 Apr 29.

Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0019085PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084737PMC
April 2011

Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers.

Carcinogenesis 2010 Feb 2;31(2):234-8. Epub 2009 Dec 2.

Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgp287DOI Listing
February 2010

Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.

Lung Cancer 2009 Aug 31;65(2):237-41. Epub 2008 Dec 31.

Section of Cancer Genetics, Brookes Lawley Building, Institute of Cancer Research, Sutton, Surrey SM2 5NG, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2008.11.012DOI Listing
August 2009

Identification of low penetrance alleles for lung cancer: the GEnetic Lung CAncer Predisposition Study (GELCAPS).

BMC Cancer 2008 Aug 20;8:244. Epub 2008 Aug 20.

Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, SM2 5NG, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-8-244DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2535604PMC
August 2008

Genetic variation in the DNA repair genes is predictive of outcome in lung cancer.

Hum Mol Genet 2007 Oct;16(19):2333-40

Section of Cancer Genetics, Institute of Cancer Research, Sutton, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddm190DOI Listing
October 2007

Lack of evidence that p53 Arg72Pro influences lung cancer prognosis: an analysis of survival in 619 female patients.

Lung Cancer 2007 Aug 2;57(2):207-12. Epub 2007 Apr 2.

Section of Cancer Genetics, Brookes Lawley Building, Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016950020700166
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2007.02.021DOI Listing
August 2007

Evaluation of xeroderma pigmentosum XPA, XPC, XPD, XPF, XPB, XPG and DDB2 genes in familial early-onset lung cancer predisposition.

Int J Cancer 2006 Aug;119(4):964-7

Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.21931DOI Listing
August 2006

Case-control study of familial lung cancer risks in UK women.

Int J Cancer 2005 Sep;116(3):445-50

Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.21012DOI Listing
September 2005

Risk of non-medullary thyroid cancer influenced by polymorphic variation in the thyroglobulin gene.

Carcinogenesis 2004 Mar 21;25(3):369-73. Epub 2003 Nov 21.

Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgh027DOI Listing
March 2004

Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis.

J Clin Oncol 2004 Feb;22(3):529-36

Section of Cancer Genetics, Institute of Cancer Research, Sutton SM2 5NG, UK.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2004.05.064
Publisher Site
http://dx.doi.org/10.1200/JCO.2004.05.064DOI Listing
February 2004